3Le T,Krepart GV,Lotocki RJ, et al.Does dedulking surgery improve survival in biologically aggressive ovarian cancer?[].Gynecologic Oncology.1997
4Vaccarello L,Rubin S C,Vlamis V,et al.Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response[].Gynecologic Oncology.1995
5Eisenkop S M,Friedman R L,Wang H J,et al.Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study[].Gynecologic Oncology.1998
6Puls L E,Dumiho T,Hunter J E,et al.The prognostic implication of ascites in advanced-stage ovarian cancer[].Gynecologic Oncology.1996
7Walther Kuhn,Stefan Rutke,Kerstin Spathe,et al.Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage ⅢC ovarian carcinoma[].Cancer.2001
8Vergote I,Dewever I,Tjalma W,et al.Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients[].Gynecologic Oncology.1998
9Ansquer Y,Leblanc E,Clough K,et al.Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study[].Cancer.2001
